GlassScriptPhysician profile
Gautam Kamthan
NPI 1376868810
$2,275.19
in general payments reported to CMS, 2019-2025
17 companies · $434 in 2025
The $434 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $43.74 · 2021: $299 · 2022: $242 · 2023: $682 · 2024: $451 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,567.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $535.76 | 2022-2025 | |
| Alcon Vision LLC | $355.37 | 2019-2024 | Clareon, Hydrus Microstent |
| Johnson & Johnson Surgical Vision, INC. | $348.82 | 2023-2024 | Tecnis Simplicity, Tecnis Iol, Tecnis Iol |
| Glaukos Corporation | $284.46 | 2021-2023 | Photrexa Cross-Linking Kit |
| New World Medical,INC. | $177.73 | 2021-2025 | Via360, Streamline, Ahmed Glaucoma Valve |
| Biotissue Holdings INC. | $167.55 | 2023-2025 | |
| Rxsight INC | $109.03 | 2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Dompe US, INC. | $95.21 | 2025 | Oxervate |
| Ivantis, INC | $45.00 | 2019 | |
| Mallinckrodt Enterprises LLC | $29.59 | 2019 | |
| Novartis Pharmaceuticals Corporation | $28.70 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $18.99 | 2025 | Xdemvy |
| Harrow Eye, LLC | $18.38 | 2025 | Vevye |
| Ocular Therapeutix, INC. | $15.38 | 2024 | Dextenza |
| Bausch & Lomb Americas INC. | $15.30 | 2024 | Vyzulta |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $15.00 | 2020 | |
| Mallinckrodt Hospital Products INC. | $14.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gautam Kamthan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.